Acta Anatomica Sinica ›› 2021, Vol. 52 ›› Issue (1): 49-54.doi: 10.16098/j.issn.0529-1356.2021.01.007

• Cancer Biology • Previous Articles     Next Articles

Inhibition of T lymphocytes secreting EphrinAl-Caspase-3 on proliferation of tumor tissue in nude mice with breast cancer

SHI Ya-qi1  TANG Xi-min1  LI Zhuang2  ZHANG Li-mei1  LU Xue-jing2  ZHOU Ling-zhi2  XU Mang HUANG Yu1  LI Yan-jiao1  ZHANG Ben-si1*   

  1. 1.Department of Anatomy, College of Basic Medicine, Dali University, Yunnan Dali671000,China; 2.Department of Thoracic Surgery, Affiliated Hospital of Dali University, Yunnan Dali671000,China
  • Received:2019-10-15 Revised:2020-01-07 Online:2021-02-06 Published:2021-02-06
  • Contact: ZHANG Ben-si E-mail:ben-si-zhang@163.com

Abstract:

Objective  To study the inhibitory effect of T lymphocytes secreting EphrinAl-Caspase-3 in vivo and on the growth of cancer cells in nude mice with breast cancer.   Methods  Nude mice(n=35)were inoculated with breast cancer cells to construct a nude mouse model of breast cancer. When the tumor volume reached 0.1 cm3, 30 nude mice with average size tumor tissue were randomly divided into PBS group,uninfected adenovirus group, T lymphocyte infected with Ad-EphrinA1-Caspase-3 group, and intratumoral transplantation. Tumor size was measured every day 2 to 3. Three groups of tumor-bearing nude mice were selected. After the above-mentioned cell transplantation, the subcutaneous tumor tissue homogenate was obtained every day 2 to 3, and the content of EphrinA1-Caspase-3 was detected by ELISA. At the end of the experiment, the animals in each group were sacrificed by cervical dissection and sliced. The presence of T lymphocytes expressing green fluorescent protein was observed under a fluorescence microscope, and Caspase-3 and Ki-67 were detected by immunofluorescence.    Results  After one week of inoculation of breast cancer cells into nude mice, the presence of subcutaneous tumors could be touched by hand, which proved that the tumor-bearing animals of breast cancer cells were successfully modeled. On the 8th day after inoculation, the tumor volume of the nude mice in each group became larger, and the difference between the treatment group and the PBS group/T lymphocyte group was extremely significant (P<0.05). Although the tumor volume of the T lymphocyte transplantation group was slower than that of the PBS control group, there was no statistically significant difference between the two. The expression of EphrinA1-Caspase-3 was detected in the EphrinA1-Caspase-3 treatment group on the 2nd day, reached the peak on the 8th day, and then the secretion decreased gradually. No expression of EphrinA1-Caspase-3 was detected in the PBS control group and the T lymphocyte group. The presence of dispersed green fluorescent protein-labeled EphrinAl-Caspase-3-T lymphocytes was observed in the tumor tissues of the treatment group, while the presence of green fluorescent protein was not detected in the PBS group and the T lymphocyte groups. In the infected cells of the treatment group, the proportion of Caspase-3 positive cells was up-regulated, and the proportion of Ki-67 positive cells was down-regulated. No expression of EphrinAl-Caspase-3 was detected in the PBS group and the T lymphocyte group.   ConclusionEphrinAl-Caspase-3 can significantly inhibit the growth of breast cancer cells, thereby exerting an anti-tumor effect.

Key words: Molecular targeted therapy,  , Breast cancer model,  , EphrinA1-Caspase-3,  , Ki67,  , Enzyme linked immunosorbent assay,  , Nude mouse

CLC Number: